Will Lewis
Chief Executive Officer chez INSMED INCORPORATED
Fortune : 18 M $ au 31/03/2024
Profil
William H.
Lewis was the founder of Aegerion Pharmaceuticals, Inc. (founded in 2005) where he held the title of President, Chief Financial Officer & Head-IR from 2005 to 2011.
He is currently the Chairman, President & Chief Executive Officer at Insmed, Inc. since 2012.
He is also the Chairman at NewAmsterdam Pharma Co. NV since 2024.
Additionally, he serves as a Director at Oberlin College and as a Trustee at Case Western Reserve University and BioNJ, Inc. In his former positions, he was a Managing Director at Wachovia Capital Markets LLC from 2002 to 2004, a Director at Insmed Innovation UK Ltd.
from 2022 to 2023, and a Principal at Robertson Stephens & Co. from 2000 to 2002.
He also served as a Vice President at J.P.
Morgan & Co., Inc. (Old) from 1995 to 2000 and as a Member-Supervisory Board at uniQure NV from 2015 to 2016.
Mr. Lewis obtained his undergraduate degree from Oberlin College and his graduate degree, as well as an MBA, from Case Western Reserve University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
INSMED INCORPORATED
0,44% | 28/02/2024 | 648 040 ( 0,44% ) | 18 M $ | 31/03/2024 |
Postes actifs de Will Lewis
Sociétés | Poste | Début |
---|---|---|
INSMED INCORPORATED | Chief Executive Officer | 10/09/2012 |
FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Chairman | 08/01/2024 |
Oberlin College | Director/Board Member | 13/08/2010 |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Director/Board Member | 01/02/2024 |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | Director/Board Member | - |
Anciens postes connus de Will Lewis
Sociétés | Poste | Fin |
---|---|---|
Insmed Innovation UK Ltd.
Insmed Innovation UK Ltd. Miscellaneous Commercial ServicesCommercial Services Adrestia Therapeutics Ltd. engages in the development of therapeutics by restoring the biological balance in damaged, diseased or dying cells. The company was founded by Stephen Philip Jackson, Gabriel Balmus, Yaron Galanty and Rafael Carazo Salas and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 30/06/2023 |
AEGERION PHARMACEUTICALS, INC. | Founder | 01/01/2011 |
Wachovia Capital Markets LLC
Wachovia Capital Markets LLC Investment Banks/BrokersFinance Wells Fargo Securities LLC is the investment bank asset management and brokerage arm of Wells Fargo & Co. (NYSE: WFC). The firm is headquartered San Francisco. Their services include fixed-income sales and trading, equities sales and trading, market analysis and research and investment banking and advisory services. | Corporate Officer/Principal | 01/04/2004 |
Robertson Stephens & Co. | Corporate Officer/Principal | 01/01/2002 |
░░░░ ░░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Will Lewis
Oberlin College | Undergraduate Degree |
Case Western Reserve University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
INSMED INCORPORATED | Health Technology |
UNIQURE N.V. | Health Technology |
FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Health Technology |
Entreprise privées | 7 |
---|---|
Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Wachovia Capital Markets LLC
Wachovia Capital Markets LLC Investment Banks/BrokersFinance Wells Fargo Securities LLC is the investment bank asset management and brokerage arm of Wells Fargo & Co. (NYSE: WFC). The firm is headquartered San Francisco. Their services include fixed-income sales and trading, equities sales and trading, market analysis and research and investment banking and advisory services. | Finance |
Robertson Stephens & Co. | Finance |
J.P. Morgan & Co., Inc. (Old) | Finance |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Insmed Innovation UK Ltd.
Insmed Innovation UK Ltd. Miscellaneous Commercial ServicesCommercial Services Adrestia Therapeutics Ltd. engages in the development of therapeutics by restoring the biological balance in damaged, diseased or dying cells. The company was founded by Stephen Philip Jackson, Gabriel Balmus, Yaron Galanty and Rafael Carazo Salas and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Helix Acquisition Corp.
Helix Acquisition Corp. Financial ConglomeratesFinance Helix Acquisition Corp. operates as a blank check company. It is a special purpose acquisition company which is incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 13, 2020 and is headquartered in Boston, MA. | Finance |